Palbonix(Palbociclib)

Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:

•  an aromatase inhibitor as initial endocrine based therapy in postmenopausal women.
• fulvestrant in women with disease progression following endocrine therapy.